TauRx To Attend AAIC 22

TauRx is attending Alzheimer’s Association International Conference in San Diego, USA, from 31 July to 4 August.
The AAIC is held each year and attracts the world’s leading scientists, clinical researchers, early career investigators, clinicians, and the care community with the aim of sharing research discoveries that will lead to methods of prevention, treatment and improvements in the diagnosis of Alzheimer’s disease.
More information about the event can be found here
TauRx has a dedicated meeting room within the exhibition hall (Exhibitor Business Suite #E0), and we are looking forward to speaking to delegates about our work.
Check back in a few weeks to read our reflections after attending the event.
Recent News
TauRx celebrates winning the Research & Development Achievement category at the Pharma Industry Awards UK 2023.
Oct 25, 2023
GT Diagnostics announces release of self-administered assessment tool aiding diagnosis of dementia, HiPAL Pro.
Sep 05, 2023
#AAIC23 may have come to a close, but we left Amsterdam with key insights that will drive our work this year.
Jul 21, 2023
TauRx’s hydromethylthionine mesylate (HMTM) demonstrates significant reduction in neurodegeneration in Alzheimer’s Disease (AD)
Jul 16, 2023